Loading insider details...
Latest Form 4 (Jun 4, 2026): Grant/Award of 9,000 KLRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 9,000 | n/a |
| Apr 11, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 18,000 | n/a |
| Mar 18, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 504,000 | n/a |
| Jun 30, 2020 | DelMar Pharmaceuticals, Inc. (DMPI) | Grant/Award | 39,567 | n/a |